Chronic conditions: The impact of delayed detection
Early detection of chronic diseases matters to the bottom line.
Read More
Pharmacy in Focus
See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.
Read More
Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs
The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...
Read More
Designing plans to manage comorbid conditions
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.
Read More
Addressing obesity in the workplace
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Read More
GLP-1s Medications 101
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read More